Company intelligence / Profile preview
Kotobuki Pharmaceutical Co., Ltd.
Sakaki-machi, Hanishina-gun, Nagano, Japankotobuki-pharm.co.jp ↗
- Ownership
- Private
- Employees
- ~130
- Development stage
- Commercial
01
Overview
Kotobuki Pharmaceutical has several approved products in the market, including Marzulene S Combination Granules for gastritis and ulcers, AZULOXA for gastric ulcers, Suglat Tablets for diabetes, SUJANU Combination Tablets for Type 2 diabetes, and XOSPATA Tablets for cancer. They also have several products in clinical development, including ASP1570 (Phase I for cancer), ASP2215/giliteritinib (Phase III for acute myeloid leukemia), and S-556971/KT6-971 (Phase II in Japan, Phase I in Europe for dyslipidemia).
- Therapeutic areas
- GastroenterologyCardiovascularEndocrinologyHematologyOncologyNeurology
- Modalities
- Small molecule drugs
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Astellas Pharma Inc.MSD
Beyond the preview
Go deeper on Kotobuki Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kotobuki Pharmaceutical Co., Ltd..